Mental Health Specialist Video Consultations for Primary Care Patients
PROVIDE-C
ImPROving Cross-sectoral Collaboration Between Primary and Psychosocial Care: A Randomised Controlled Superiority Trial to Compare the Effectiveness of a Mental Health Specialist VIDEo Consultations Model Versus Treatment as Usual in Patients With Depression or Anxiety Disorders in Primary Care
1 other identifier
interventional
376
1 country
1
Brief Summary
Even in Western health care systems, most people with mental disorders, including those with severe and chronic disorders, are treated solely by their general practitioner (GP). Notably, the accessibility of mental health specialist care is mainly complicated by (a) long waiting times for specialists, (b) long travel distances to specialists, particularly in rural and remote areas, (c) patients' reservations about mental health specialist care (including fear of being stigmatised by seeking such care). To mitigate those barriers, technology-based integrated care models have been proposed. The purpose of this study is to measure the effectiveness of a mental health specialist video consultations model versus treatment as usual in patients with depression or anxiety disorders in primary care. In an individually randomized, prospective, two-arm superiority study with parallel group design, N = 320 patients with anxiety and/or depressive disorder will be recruited in GP practices.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable depression
Started Mar 2020
Typical duration for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 18, 2020
CompletedFirst Posted
Study publicly available on registry
March 20, 2020
CompletedStudy Start
First participant enrolled
March 24, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 24, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 18, 2022
CompletedAugust 1, 2023
July 1, 2023
2.2 years
March 18, 2020
July 30, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The Patient Health Questionnaire Depression and Anxiety Scale (PHQ-ADS)
composite measure of depression and anxiety (range: 0-48 Points, higher score indicates more severly depressed/anxious)
6 months after inclusion
Secondary Outcomes (9)
The Patient Health Questionnaire Depression and Anxiety Scale (PHQ-ADS)
12 months after inclusion
The Patient Health Questionnaire (PHQ-9)
6 months after inclusion, 12 months after inclusion
Generalized Anxiety Disorder Scale (GAD-7)
6 months after inclusion, 12 months after inclusion
Short-Form Health Survey 12 (SF-12)
6 months after inclusion, 12 months after inclusion
Recovery Assessment Scale (RAS-G)
6 months after inclusion, 12 months after inclusion
- +4 more secondary outcomes
Other Outcomes (2)
Assessment of Negative Effects of Psychotherapy (INEP)
6 months after inclusion, 12 months after inclusion (not measured at baseline, patients in control condition fill in adapted version)
Normalisation MeAsure Development questionnaire (NoMAD)
6 months after inclusion, 12 months after inclusion (measured in GPs and study therapists only)
Study Arms (2)
mental health specialist video consultation
EXPERIMENTALThe intervention group will receive five video consultations with psychotherapists directly in the GP's practice. The consultations will be carried out via the web portal of a certified video service provider (arztkonsultation ak GmbH). The patient will be located in the GP's practice and the psychotherapist in his practice or another suitable room. Patients are scheduled for five sessions of 50 minutes.
treatment as usual by the GP
NO INTERVENTIONRoutine treatment by the GP, which may or may not include conversations about psychosocial problems and/or referral to specialised services (e.g., inpatient therapy, counseling, self-help).
Interventions
The consultations will be based on a psychodynamic understanding with a solution-oriented stance and will follow a manual: Session 1: Getting familiar with the telemental health setting, building a working alliance and deepening diagnostics. Session 2: Clarification of the task/objective, focus building, motivational interviewing if necessary. Session 3-4: Focused brief interventions e.g. psychoeducation, promotion of social resources, activation of health-promoting lifestyles (sleep hygiene, eating diary, relaxation etc.), work on personal problems and, if necessary, initiation of further specialised treatment. Session 5: Ending the intervention, stabilisation, subsequent treatment plan and communicating a case summary to the general practitioner
Eligibility Criteria
You may qualify if:
- at least one of the following psychological conditions i) at least moderately severe depression, defined as a PHQ-9 score of 10 or greater with either item one and/or two being endorsed, ii) at least moderately general anxiety disorder, defined as a Generalized Anxiety Disorder (GAD)-7 score of 10 or greater, or iii) exceeding the cut off of 11 points of the combined anxiety and depression score (PHQ-ADS)
- currently no or as yet insufficient treatment (psychotherapy, psychopharmacotherapy, or both) or difficulty with adherence
- capable of giving consent
- written informed consent
You may not qualify if:
- substance abuse/dependence that is likely to compromise intervention adherence
- risk of endangerment to others and/or risk of self-endangerment
- need for emergency medical treatment
- acute psychotic symptoms
- severe cognitive impairment or dementia
- significant hearing and/or visual impairment
- pregnancy in the ≥ 2nd Trimester
- prior experience with video consultations as part of the feasibility trial
- insufficient German language proficiency
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Heidelberg Universitylead
- Heinrich-Heine University, Duesseldorfcollaborator
Study Sites (1)
Heidelberg University
Heidelberg, Baden-Wurttemberg, D-69120, Germany
Related Publications (4)
Muller S, Ritter-von Kramer A, Tonnies J, Wildenauer A, Wensing M, Friederich HC, Haun MW. Engaging underrepresented patient groups in specialised treatment - qualitative results from the PROVIDE-C randomised trial on integrated mental health video consultations for depression and anxiety. BMC Public Health. 2025 Nov 6;25(1):3817. doi: 10.1186/s12889-025-25235-1.
PMID: 41199204DERIVEDvan Eickels D, Henning K, Wensing M, Friederich HC, Haun MW. Psychometric validation of the German version of the somatic symptom disorder - B criteria scale (SSD-12) in a primary care population with depression and anxiety: A COSMIN-guided analysis. Gen Hosp Psychiatry. 2025 Nov-Dec;97:3-10. doi: 10.1016/j.genhosppsych.2025.09.001. Epub 2025 Sep 4.
PMID: 40939424DERIVEDHaun MW, Tonnies J, Hartmann M, Wildenauer A, Wensing M, Szecsenyi J, Feisst M, Pohl M, Vomhof M, Icks A, Friederich HC. Model of integrated mental health video consultations for people with depression or anxiety in primary care (PROVIDE-C): assessor masked, multicentre, randomised controlled trial. BMJ. 2024 Sep 25;386:e079921. doi: 10.1136/bmj-2024-079921.
PMID: 39322237DERIVEDHaun MW, Tonnies J, Krisam R, Kronsteiner D, Wensing M, Szecsenyi J, Vomhof M, Icks A, Wild B, Hartmann M, Friederich HC. Mental health specialist video consultations versus treatment as usual in patients with depression or anxiety disorders in primary care: study protocol for an individually randomised superiority trial (the PROVIDE-C trial). Trials. 2021 May 5;22(1):327. doi: 10.1186/s13063-021-05289-3.
PMID: 33952313DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Markus W Haun, MD, MSc
Department of General Internal Medicine and Psychosomatics, Heidelberg University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Internal Medicine Specialist and Head of the Junior Research Group PROVIDE
Study Record Dates
First Submitted
March 18, 2020
First Posted
March 20, 2020
Study Start
March 24, 2020
Primary Completion
May 24, 2022
Study Completion
November 18, 2022
Last Updated
August 1, 2023
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF, ANALYTIC CODE